In vitro (human lymphocytes) · PMID 12533768
Effects of Livagen peptide on chromatin activation in lymphocytes from old people — VialBase Research
The most Livagen-specific human mechanistic study; basis for the chromatin-activation mechanism.
Last updated · 2002 · Khavinson VKh et al. · Bull Exp Biol Med
Key findings
- Livagen decondensed (activated) heterochromatin in lymphocytes from elderly subjects
- Reactivated previously silenced ribosomal genes, reversing an age-related chromatin change
Livagen chromatin activation in ageing lymphocytes (PMID: 12533768)
Summary
In lymphocytes from older people, Livagen activated condensed chromatin and reactivated ribosomal genes — a named, compound-specific demonstration of its epigenetic mechanism.
Relevance
Cornerstone mechanistic evidence for Livagen. Mechanistic, not a clinical-outcome study.
See Also
- Parent compound: Livagen
Where to buy Livagen
Livagen4 vetted vendors
BioLongevity LabsVisit BioLongevity Labs →
Save 15% with code VIALBASE
VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.